HAL will be down for maintenance from Friday, June 10 at 4pm through Monday, June 13 at 9am. More information
Skip to Main content Skip to Navigation
Journal articles

Catching the Therapeutic Window of Opportunity in Early Crohn’s Disease

Abstract : Crohn's disease (CD) is a chronic, disabling, progressive and destructive disease. The general goal of conventional step-up strategy in CD treatment is to treat and control symptoms. This strategy did not change the disease course and is now being replaced with a treat-to-target approach. Achieving deep remission (clinical remission and absence of mucosal ulcerations) is the target in CD in 2014. Inducing and maintaining deep remission is needed to prevent long-term outcomes such as bowel damage and disability in CD. Diagnostic delay is a common issue in CD and is associated with an increased risk of bowel damage over time. Identification of poor prognostic factors, risk stratification together with the development of "red flags" may result in early intervention with disease-modifying agents such as anti-TNF agents with the final aim of preventing overtreatment and avoiding undertreatment. Similar to rheumatoid arthritis, by catching the therapeutic window of opportunity in early CD and achieving deep remission, this could be the best way to change disease course (hospitalizations, surgeries, bowel damage, and disability) and patients' life.
Document type :
Journal articles
Complete list of metadata

Contributor : Ngere Ul Connect in order to contact the contributor
Submitted on : Thursday, January 18, 2018 - 2:22:50 PM
Last modification on : Tuesday, October 13, 2020 - 10:46:37 AM




Silvio Danese, Gionata Fiorino, Carlos Fernandes, Laureal Peyrin-Biroulet. Catching the Therapeutic Window of Opportunity in Early Crohn’s Disease. Current Drug Targets, Bentham Science Publishers, 2014, 15 (11), pp.1056 - 1063. ⟨10.2174/1389450115666140908125738⟩. ⟨hal-01687387⟩



Record views